SIC
Starr International Company Portfolio holdings
AUM
$19.9M
This Quarter Return
+35.77%
1 Year Return
-39.69%
3 Year Return
-26.08%
5 Year Return
-43.79%
10 Year Return
-39.24%
AUM
$39.6M
AUM Growth
+$39.6M
(+28%)
Cap. Flow
+$137K
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Bain Capital Specialty
BCSF
|
$137K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 62.13% |
| 2 | Financials | 37.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $15.7M | 39.75% | 67,000 | – | – |
|
|
2
Bain Capital Specialty
BCSF
$1.03B
| $12M | 30.32% | 784,890 +8,964 | +1% | +$137K |
|
3
AstraZeneca
AZN
$248B
| $5.57M | 14.07% | 93,000 | – | – |
|
4
Johnson & Johnson
JNJ
$427B
| $3.3M | 8.32% | 20,000 | – | – |
|
5
American International
AIG
$45.1B
| $2.99M | 7.55% | 62,788 | – | – |
|